IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biohaven Pharmaceutical Holding Co. Ltd (BHVN)

CUSIP: G111OE107 | Healthcare · Biotechnology | Mid Cap | 1 institutional holders

Quarters

Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Knott David M Jr60,720
0.3% of portfolio›$513.7K
StyleTurnoverLocationFiled
Knott David M Jr
60,720$513.7K0.3%GrowthMediumSyosset, NY2026-05-14